These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8477148)

  • 1. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type.
    Parnetti L; Abate G; Bartorelli L; Cucinotta D; Cuzzupoli M; Maggioni M; Villardita C; Senin U
    Drugs Aging; 1993; 3(2):159-64. PubMed ID: 8477148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M
    Neurology; 1991 Nov; 41(11):1726-32. PubMed ID: 1944900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN
    Curr Med Res Opin; 1990; 11(10):638-47. PubMed ID: 2178869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain.
    Onofrj M; Fulgente T; Melchionda D; Marchionni A; Tomasello F; Salpietro FM; Alafaci C; De Sanctis E; Pennisi G; Bella R
    Int J Clin Pharmacol Res; 1995; 15(1):9-15. PubMed ID: 7490173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.
    Pettegrew JW; Klunk WE; Panchalingam K; Kanfer JN; McClure RJ
    Neurobiol Aging; 1995; 16(1):1-4. PubMed ID: 7723928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia.
    Campi N; Todeschini GP; Scarzella L
    Clin Ther; 1990; 12(4):306-14. PubMed ID: 2121359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study.
    Senin U; Abate G; Fieschi C; Gori G; Guala A; Marini G; Villardita C; Parnetti L
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):511-7. PubMed ID: 1822317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.
    Thal LJ; Carta A; Clarke WR; Ferris SH; Friedland RP; Petersen RC; Pettegrew JW; Pfeiffer E; Raskind MA; Sano M; Tuszynski MH; Woolson RF
    Neurology; 1996 Sep; 47(3):705-11. PubMed ID: 8797468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.
    Sano M; Bell K; Cote L; Dooneief G; Lawton A; Legler L; Marder K; Naini A; Stern Y; Mayeux R
    Arch Neurol; 1992 Nov; 49(11):1137-41. PubMed ID: 1444880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Kalyn IaB; Kolykhalov IV; Roshchina IF; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):16-22. PubMed ID: 22027664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease.
    Calvani M; Carta A; Caruso G; Benedetti N; Iannuccelli M
    Ann N Y Acad Sci; 1992 Nov; 663():483-6. PubMed ID: 1482095
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
    Montgomery SA; Thal LJ; Amrein R
    Int Clin Psychopharmacol; 2003 Mar; 18(2):61-71. PubMed ID: 12598816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-carnitine and Alzheimer's disease.
    Bowman BA
    Nutr Rev; 1992 May; 50(5):142-4. PubMed ID: 1630720
    [No Abstract]   [Full Text] [Related]  

  • 18. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia.
    Di Perri R; Coppola G; Ambrosio LA; Grasso A; Puca FM; Rizzo M
    J Int Med Res; 1991; 19(4):330-41. PubMed ID: 1916007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease?
    Carta A; Calvani M
    Ann N Y Acad Sci; 1991; 640():228-32. PubMed ID: 1776743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An example of a clinical trial in patients with Alzheimer's disease: some methodological issues.
    Lucca U; Menasce G; Comelli M; Cizza G; Bressi S; Frattura L; Tiraboschi P; Spagnoli A
    Prog Clin Biol Res; 1989; 317():1301-10. PubMed ID: 2690098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.